Literature DB >> 21751231

Robust extraction of covariate information to improve estimation efficiency in randomized trials.

Kelly L Moore1, Romain Neugebauer, Thamban Valappil, Mark J Laan.   

Abstract

In randomized trials, investigators typically rely upon an unadjusted estimate of the mean outcome within each treatment arm to draw causal inferences. Statisticians have underscored the gain in efficiency that can be achieved from covariate adjustment in randomized trials with a focus on problems involving linear models. Despite recent theoretical advances, there has been a reluctance to adjust for covariates based on two primary reasons: (i) covariate-adjusted estimates based on conditional logistic regression models have been shown to be less precise and (ii) concern over the opportunity to manipulate the model selection process for covariate adjustments to obtain favorable results. In this paper, we address these two issues and summarize recent theoretical results on which is based a proposed general methodology for covariate adjustment under the framework of targeted maximum likelihood estimation in trials with two arms where the probability of treatment is 50%. The proposed methodology provides an estimate of the true causal parameter of interest representing the population-level treatment effect. It is compared with the estimates based on conditional logistic modeling, which only provide estimates of subgroup-level treatment effects rather than marginal (unconditional) treatment effects. We provide a clear criterion for determining whether a gain in efficiency can be achieved with covariate adjustment over the unadjusted method. We illustrate our strategy using a resampled clinical trial dataset from a placebo controlled phase 4 study. Results demonstrate that gains in efficiency can be achieved even with binary outcomes through covariate adjustment leading to increased statistical power.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21751231      PMCID: PMC4113477          DOI: 10.1002/sim.4301

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  14 in total

1.  Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.

Authors:  Adrián V Hernández; Ewout W Steyerberg; J Dik F Habbema
Journal:  J Clin Epidemiol       Date:  2004-05       Impact factor: 6.437

2.  Asymptotic optimality of likelihood-based cross-validation.

Authors:  Mark J van der Laan; Sandrine Dudoit; Sunduz Keles
Journal:  Stat Appl Genet Mol Biol       Date:  2004-03-22

3.  Testing for imbalance of covariates in controlled experiments.

Authors:  T Permutt
Journal:  Stat Med       Date:  1990-12       Impact factor: 2.373

4.  Suspended judgment. Significance tests of covariate imbalance in clinical trials.

Authors:  C B Begg
Journal:  Control Clin Trials       Date:  1990-08

5.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

6.  A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods.

Authors:  J Robins
Journal:  J Chronic Dis       Date:  1987

7.  Testing for baseline balance in clinical trials.

Authors:  S Senn
Journal:  Stat Med       Date:  1994-09-15       Impact factor: 2.373

8.  Covariate adjustment in randomized trials with binary outcomes: targeted maximum likelihood estimation.

Authors:  K L Moore; M J van der Laan
Journal:  Stat Med       Date:  2009-01-15       Impact factor: 2.373

9.  Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.

Authors:  Stuart J Pocock; Susan E Assmann; Laura E Enos; Linda E Kasten
Journal:  Stat Med       Date:  2002-10-15       Impact factor: 2.373

10.  Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.

Authors:  Anastasios A Tsiatis; Marie Davidian; Min Zhang; Xiaomin Lu
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

View more
  7 in total

1.  Adaptive pre-specification in randomized trials with and without pair-matching.

Authors:  Laura B Balzer; Mark J van der Laan; Maya L Petersen
Journal:  Stat Med       Date:  2016-07-19       Impact factor: 2.373

2.  Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials.

Authors:  Shuai Yuan; Hao Helen Zhang; Marie Davidian
Journal:  Stat Med       Date:  2012-06-26       Impact factor: 2.373

3.  Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials.

Authors:  Fan Li; Ashley L Buchanan; Stephen R Cole
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2022-03-17       Impact factor: 1.680

4.  The Diabetes Telephone Study: Design and challenges of a pragmatic cluster randomized trial to improve diabetic peripheral neuropathy treatment.

Authors:  Alyce S Adams; Elizabeth A Bayliss; Julie A Schmittdiel; Andrea Altschuler; Wendy Dyer; Romain Neugebauer; Marc Jaffe; Joseph D Young; Eileen Kim; Richard W Grant
Journal:  Clin Trials       Date:  2016-03-31       Impact factor: 2.486

5.  Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes.

Authors:  David Benkeser; Iván Díaz; Alex Luedtke; Jodi Segal; Daniel Scharfstein; Michael Rosenblum
Journal:  medRxiv       Date:  2020-06-11

6.  Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes.

Authors:  David Benkeser; Iván Díaz; Alex Luedtke; Jodi Segal; Daniel Scharfstein; Michael Rosenblum
Journal:  Biometrics       Date:  2020-10-11       Impact factor: 1.701

7.  Viability of an Early Sleep Intervention to Mitigate Poor Sleep and Improve Well-being in the COVID-19 Pandemic: Protocol for a Feasibility Randomized Controlled Trial.

Authors:  Kathleen Patricia O'Hora; Raquel A Osorno; Dena Sadeghi-Bahmani; Mateo Lopez; Allison Morehouse; Jane P Kim; Rachel Manber; Andrea N Goldstein-Piekarski
Journal:  JMIR Res Protoc       Date:  2022-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.